189 related articles for article (PubMed ID: 16950819)
1. Novel NHLRC1 mutations and genotype-phenotype correlations in patients with Lafora's progressive myoclonic epilepsy.
Singh S; Sethi I; Francheschetti S; Riggio C; Avanzini G; Yamakawa K; Delgado-Escueta AV; Ganesh S
J Med Genet; 2006 Sep; 43(9):e48. PubMed ID: 16950819
[TBL] [Abstract][Full Text] [Related]
2. Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype.
Ganesh S; Delgado-Escueta AV; Suzuki T; Francheschetti S; Riggio C; Avanzini G; Rabinowicz A; Bohlega S; Bailey J; Alonso ME; Rasmussen A; Thomson AE; Ochoa A; Prado AJ; Medina MT; Yamakawa K
Hum Mol Genet; 2002 May; 11(11):1263-71. PubMed ID: 12019207
[TBL] [Abstract][Full Text] [Related]
3. Lafora's disease: towards a clinical, pathologic, and molecular synthesis.
Minassian BA
Pediatr Neurol; 2001 Jul; 25(1):21-9. PubMed ID: 11483392
[TBL] [Abstract][Full Text] [Related]
4. Mutations in the NHLRC1 gene are the common cause for Lafora disease in the Japanese population.
Singh S; Suzuki T; Uchiyama A; Kumada S; Moriyama N; Hirose S; Takahashi Y; Sugie H; Mizoguchi K; Inoue Y; Kimura K; Sawaishi Y; Yamakawa K; Ganesh S
J Hum Genet; 2005; 50(7):347-352. PubMed ID: 16021330
[TBL] [Abstract][Full Text] [Related]
5. Lafora disease in the Indian population: EPM2A and NHLRC1 gene mutations and their impact on subcellular localization of laforin and malin.
Singh S; Satishchandra P; Shankar SK; Ganesh S
Hum Mutat; 2008 Jun; 29(6):E1-12. PubMed ID: 18311786
[TBL] [Abstract][Full Text] [Related]
6. Recent advances in the molecular basis of Lafora's progressive myoclonus epilepsy.
Ganesh S; Puri R; Singh S; Mittal S; Dubey D
J Hum Genet; 2006; 51(1):1-8. PubMed ID: 16311711
[TBL] [Abstract][Full Text] [Related]
7. [Lafora's disease presenting with progressive myoclonus epilepsy].
Béjot Y; Lemesle-Martin M; Contégal F; Graule-Petot A; Thauvin C; Aubriot-Lorton MH; Moreau T; Giroud M
Rev Neurol (Paris); 2007 Oct; 163(10):975-8. PubMed ID: 18033035
[TBL] [Abstract][Full Text] [Related]
8. Mutation spectrum and predicted function of laforin in Lafora's progressive myoclonus epilepsy.
Minassian BA; Ianzano L; Meloche M; Andermann E; Rouleau GA; Delgado-Escueta AV; Scherer SW
Neurology; 2000 Aug; 55(3):341-6. PubMed ID: 10932264
[TBL] [Abstract][Full Text] [Related]
9. Severe and rapidly-progressive Lafora disease associated with NHLRC1 mutation: a case report.
Casciato S; Gambardella S; Mascia A; Quarato PP; D'Aniello A; Ackurina Y; Albano V; Fornai F; Scala S; Di Gennaro G
Int J Neurosci; 2017 Dec; 127(12):1150-1153. PubMed ID: 28556688
[TBL] [Abstract][Full Text] [Related]
10. Lafora progressive myoclonus epilepsy: a meta-analysis of reported mutations in the first decade following the discovery of the EPM2A and NHLRC1 genes.
Singh S; Ganesh S
Hum Mutat; 2009 May; 30(5):715-23. PubMed ID: 19267391
[TBL] [Abstract][Full Text] [Related]
11. Mutation screening for Japanese Lafora's disease patients: identification of novel sequence variants in the coding and upstream regulatory regions of EPM2A gene.
Ganesh S; Shoda K; Amano K; Uchiyama A; Kumada S; Moriyama N; Hirose S; Yamakawa K
Mol Cell Probes; 2001 Oct; 15(5):281-9. PubMed ID: 11735300
[TBL] [Abstract][Full Text] [Related]
12. Two novel mutations in the EPM2A gene in a Korean patient with Lafora's progressive myoclonus epilepsy.
Ki CS; Kong SY; Seo DW; Hong SB; Kim HJ; Kim JW
J Hum Genet; 2003; 48(1):51-4. PubMed ID: 12560877
[TBL] [Abstract][Full Text] [Related]
13. Three patients with lafora disease: different clinical presentations and a novel mutation.
Poyrazoğlu HG; Karaca E; Per H; Gümüs H; Onay H; Canpolat M; Canöz Ö; Ozkınay F; Kumandas S
J Child Neurol; 2015 May; 30(6):777-81. PubMed ID: 25015673
[TBL] [Abstract][Full Text] [Related]
14. Rapidly progressive phenotype of Lafora disease associated with a novel NHLRC1 mutation.
Brackmann FA; Kiefer A; Agaimy A; Gencik M; Trollmann R
Pediatr Neurol; 2011 Jun; 44(6):475-7. PubMed ID: 21555062
[TBL] [Abstract][Full Text] [Related]
15. Four novel and two recurrent NHLRC1 (EPM2B) and EPM2A gene mutations leading to Lafora disease in six Turkish families.
Salar S; Yeni N; Gündüz A; Güler A; Gökçay A; Velioğlu S; Gündoğdu A; Hande Çağlayan S
Epilepsy Res; 2012 Feb; 98(2-3):273-6. PubMed ID: 22047982
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic data on Lafora disease patients of Serbian/Montenegrin origin.
Kecmanović M; Jović N; Keckarević-Marković M; Keckarević D; Stevanović G; Ignjatović P; Romac S
Clin Genet; 2016 Jan; 89(1):104-8. PubMed ID: 25683376
[TBL] [Abstract][Full Text] [Related]
17. [Progressive myoclonic epilepsy secondary to Lafora's body disease].
Potes T; Galicchio S; Rosso B; Besocke G; García MDC; Avalos JC
Medicina (B Aires); 2018; 78(6):436-439. PubMed ID: 30504111
[TBL] [Abstract][Full Text] [Related]
18. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.
Couarch P; Vernia S; Gourfinkel-An I; Lesca G; Gataullina S; Fedirko E; Trouillard O; Depienne C; Dulac O; Steschenko D; Leguern E; Sanz P; Baulac S
J Mol Med (Berl); 2011 Sep; 89(9):915-25. PubMed ID: 21505799
[TBL] [Abstract][Full Text] [Related]
19. Lafora disease: severe phenotype associated with homozygous deletion of the NHLRC1 gene.
Kecmanović M; Jović N; Cukić M; Keckarević-Marković M; Keckarević D; Stevanović G; Romac S
J Neurol Sci; 2013 Feb; 325(1-2):170-3. PubMed ID: 23317923
[TBL] [Abstract][Full Text] [Related]
20. Novel mutations in EPM2A and NHLRC1 widen the spectrum of Lafora disease.
Lesca G; Boutry-Kryza N; de Toffol B; Milh M; Steschenko D; Lemesle-Martin M; Maillard L; Foletti G; Rudolf G; Nielsen JE; á Rogvi-Hansen B; Erdal J; Mancini J; Thauvin-Robinet C; M'Rrabet A; Ville D; Szepetowski P; Raffo E; Hirsch E; Ryvlin P; Calender A; Genton P
Epilepsia; 2010 Sep; 51(9):1691-8. PubMed ID: 20738377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
